Clinical trial Recruiting at 1 site Observational Ages 18 and up

Laminoplasty for cervical spine issues using MRI techniques

Official title: Feasibility and Clinical Applicability of Surgical Segments Choice for Laminoplasty in Multilevel Cervical Spondylotic Myelopathy Guided by Modified K-line and Modified SC-line in MRI

Run by Affiliated 2 Hospital of Nantong University · NCT06478485 · Data updated 2026-11-12

This study is testing how certain MRI techniques can help doctors make better decisions about surgery for patients with neck problems caused by spinal cord issues.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorAffiliated 2 Hospital of Nantong University
Academic / other
Locations1 site (Nantong, Jiangsu)
StatusRecruiting
StartedJanuary 1, 2020
Main results expectedDecember 30, 2026
Study endsDecember 30, 2027
Registry record updatedJuly 1, 2024
Trial IDNCT06478485 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients diagnosed with multilevel cervical spondylotic myelopathy who are scheduled for laminoplasty surgery and have specific MRI characteristics.

Probably not a fit

Patients with previous cervical spine surgery or other neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the impact of modified K-line and modified SC-line on surgical decision-making for patients with multilevel cervical spondylotic myelopathy (MCSM). It will collect MRI data from patients undergoing laminoplasty (LAMP) surgery to determine how these imaging techniques can predict surgical outcomes and decompression effectiveness. The study focuses on patients with specific MRI characteristics that may influence their prognosis post-surgery. By analyzing these factors, the study seeks to enhance the understanding of optimal surgical approaches for MCSM.

Why it matters

Potential benefit: If successful, this study could improve surgical outcomes for patients with multilevel cervical spondylotic myelopathy by refining surgical decision-making.

How similar studies have gone: While this approach is novel in its combination of imaging techniques for surgical decision-making, similar studies have shown promise in improving surgical outcomes in related conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

(1) Diagnosis of MCSM confirmed by two spine surgeons with MRI examination and clinic signs; (2) More than 2 level lesions and/or spinal stenosis in MRI, underwent LAMP surgery; (3) Available for both preoperative and follow-up imaging data and clinical data, including sex, age, clinical symptoms, Japanese Orthopedic Association (JOA) score, Visual Analog Scale (VAS) score, Neck Disability Index(NDI) score and MRI data.

Exclusion Criteria:

(1) Previous cervical spine surgery; (2) Diagnosis of tumor, central cord syndrome, infection or other acute traumatic injuries; (3) Diagnosed neurological disorders Parkinson's disease, polio, multiple sclerosis, or other central and peripheral nervous system diseases).

Where it's running

  • The Second Affiliated Hospital of Nantong University
    Nantong, Jiangsu, China
    Recruiting

Study contacts

  • Principal investigator: Zhiming Cui, Professor — Second Affiliated Hospital of Nantong University
  • Study coordinator: Chunshuai Wu, Doctor
  • Email: wcsspine@ntu.edu.cn
  • Phone: +8613861989196

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.